Skip to main content
  • Regular Beta-Blocker Use Associated with Better Peripartum Cardiomyopathy Outcomes in Nigerian Study

    Regular use of beta-blockers was associated with better outcomes for women with peripartum cardiomyopathy (PPCM) in a 244-patient study in Nigeria, the country with the world’s highest incidence of the pregnancy complication.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details